Jian Sha

The University of Texas Medical Branch at Galveston — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

39h-index4.3kcitations90works5.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Yersinia bacterium, plague, ectoparasites research(36), Aquaculture disease management and microbiota(32), Vibrio bacteria research studies(31), Vector-borne infectious diseases(20), Bacteriophages and microbial interactions(18)

Publications90 total

Protective mechanism of action of the antifungal drug naftifine against <i>Mycobacterium abscessus</i> infection
Antimicrobial Agents and Chemotherapy·2026Open Access
- Clinical trends of Aeromonas infections in the Gulf Coast Region and genetic comparisons of clinical versus environmental isolates
One Health·2025Open Access
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines
Small Science·2025Open Access
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines
Small Science·2025· 1 citedOpen Access
Combination of live attenuated and adenovirus-based vaccines completely protects interferon gamma (IFNγ) knockout mice against pneumonic plague
2024Open Access
The Protective Effect of IL-17A in Pneumonic Plague Can Be Compensated by Effective Vaccines and Immunization Strategies in Mice
Vaccines·2024· 3 citedOpen Access
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal Vaccines
2024Open Access
A bacteriophage cocktail targeting <i>Yersinia pestis</i> provides strong post-exposure protection in a rat pneumonic plague model
Microbiology Spectrum·2024· 5 citedOpen Access
Progress on the research and development of plague vaccines with a call to action
npj Vaccines·2024· 14 citedOpen Access
Clinical Presentation, Antimicrobial Resistance, and Treatment Outcomes of <i>Aeromonas</i> Human Infections: A 14-Year Retrospective Study and Comparative Genomics of 2 Isolates From Fatal Cases
Clinical Infectious Diseases·2024· 11 citedOpen Access
Antimicrobial resistance in aeromonads and new therapies targeting quorum sensing
Applied Microbiology and Biotechnology·2024· 25 citedOpen Access
A Bacteriophage Cocktail Targeting <i>Yersinia pestis</i> Provides Strong Post-Exposure Protection in a Rat Pneumonic Plague Model
2024· 2 citedOpen Access
FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy
Microbiology Spectrum·2022· 22 citedOpen Access
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
mBio·2022· 31 citedOpen Access
A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine
2022· 3 citedOpen Access
Combinatorial viral vector-based and live-attenuated vaccines without an adjuvant to generate broader immune responses to effectively combat pneumonic plague
2021Open Access
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering
Science Advances·2021· 67 citedOpen Access
A new generation needle- and adjuvant-free trivalent plague vaccine utilizing adenovirus-5 nanoparticle platform
npj Vaccines·2021· 21 citedOpen Access
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR Engineering
2021· 9 citedOpen Access
643 HOST-DIRECTED DRUG CANDIDATES TO COMBAT CLOSTRIDIOIDES DIFFICILE INFECTION
Gastroenterology·2020
page 1 of 5Next →

Frequent Co-authors

Ashok K. Chopra(49), Tatiana E. Erova(25), Michelle L. Kirtley(14), Giovanni Suárez(12), Amin A. Fadl(12), Елена Козлова(12), Sheri M. Foltz(10), Amy J. Horneman(9), Eric C. Fitts(9), Johanna C. Sierra(8), Bijay K. Khajanchi(8), Christina J. van Lier(8), Cristi L. Galindo(8), Shaofei Wang(7), Vsevolod L. Popov(7), Johnny W. Peterson(7), Wallace B. Baze(7), Stacy L. Agar(6), Duraisamy Ponnusamy(5), Jourdan A. Andersson(5)